1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Bronchopulmonary Dysplasia - Epidemiology Forecast to 2030

Bronchopulmonary Dysplasia - Epidemiology Forecast to 2030

  • February 2021
  • 225 pages
  • ID: 6028058
  • Format: PDF
  • Delve Insight

Summary

Table of Contents

‘Bronchopulmonary Dysplasia (BPD) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the BPD, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
BPD Disease Understanding
Bronchopulmonary Dysplasia (BPD) also known as Chronic Lung Disease of infancy is a serious lung condition that affects newborns. BPD mostly affects premature newborns who need oxygen therapy, which is oxygen given through nasal prongs, a mask, or a breathing tube.
If premature newborns still require oxygen therapy by the time, they reach 36 weeks gestation, they are diagnosed with BPD. BPD develops as a result of a newborn’s lungs not developing normally while the baby is growing in the womb or not developing fully if the baby was born prematurely. These babies’ lungs are fragile and can be easily irritated or inflamed after birth. Most newborns who develop BPD are born more than 10 weeks before their due dates, weigh less than 2 pounds at birth, and have breathing problems. Infections that occur before or shortly after birth also can contribute to BPD.
The first sign of BPD is when premature newborns—usually those born more than 10 weeks early—still need oxygen therapy by the time they reach 36 weeks gestation. Newborns who have severe BPD may have trouble feeding, which can lead to delayed growth. These babies also may develop pulmonary hypertension and Cor pulmonale, which is the failure of the right side of the heart.
BPD can be mild, moderate, or severe. The diagnosis depends on how much extra oxygen a baby needs at the time of the original due date. It also depends on how long the baby needs oxygen therapy.

BPD Epidemiology
The BPD epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of our report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings
The total incident cases of BPD patients are increasing in the geographies during the study period, i.e., 2017–2030.
The disease epidemiology covered in the report provides historical as well as forecasted BPD symptoms epidemiology segmented as the Total Preterm Births, Total Preterm Births Based on Gestation Week, Total cases of BPD, Total incident cases of BPD based on Gestation Period, Total incident cases of BPD based on Birth Weight, and Severity of specific cases of BPD. The report includes the incident scenario of BPD symptoms in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden from 2017 to 2030.

Country-wise - BPD Epidemiology
The epidemiology segment also provides the BPD epidemiology data and findings across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
The total number of incident cases of BPD was 165,274 in 2020.
• As per the estimates, India has the largest incident population of BPD.
• Among the EU5 countries, Germany had the highest incident cases of BPD, followed by the UK. On the other hand, Spain had the lowest incident cases, with 859 cases in 2020 in EU5.

Scope of the Report
• The BPD report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
• The BPD Epidemiology Report and Model provide an overview of the risk factors and global trends of BPD in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
• The report provides insight into the historical and forecasted patient pool of BPD in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
• The report helps to recognize the growth opportunities concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of BPD.
• The report provides the segmentation of the BPD epidemiology by total preterm births in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
• The report provides the segmentation of the BPD epidemiology by total preterm births based on gestation week in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
• The report provides the segmentation of the BPD epidemiology by total cases of BPD in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
• The report provides the segmentation of the BPD epidemiology by total incident cases of BPD based on gestation period in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
• The report provides the segmentation of the BPD epidemiology by total incident cases of BPD based on birth weight in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
• The report provides the segmentation of the BPD epidemiology by the severity of specific cases of BPD in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.

Report Highlights

• 11-year Forecast of BPD epidemiology
• The United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden Coverage
• Incident Cases according to segmentation: Total Preterm Births
• Incident Cases according to segmentation: Total Preterm Births Based on Gestation Week
• Incident Cases according to segmentation: Total cases of BPD
• Incident Cases according to segmentation: Total incident cases of BPD based on Gestation Period
• Incident Cases according to segmentation: Total incident cases of BPD based on Birth Weight
• Incident Cases according to segmentation: Severity of specific cases of BPD

KOL Views
We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered
• What will be the growth opportunities for the patient population of BPD?
• What are the key findings of the BPD epidemiology across the different geographies and which country will have the highest number of patients during the forecast period (2017–2030)?
• What would be the total number of patients with BPD across the different geographies during the forecast period (2017–2030)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017–2030)?
• At what CAGR the patient population is expected to grow during the forecast period (2017–2030)?
• What are the disease risk, burdens, and unmet needs of the BPD?
• What are the currently available treatments for BPD?

Reasons to buy
The BPD epidemiology report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global BPD market
• Quantify patient populations in the global BPD market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for BPD therapeutics in each of the markets covered
• Understand the magnitude of the total preterm births.
• Understand the magnitude of the total preterm births based on gestation week.
• Understand the magnitude of the total cases of BPD.
• Understand the magnitude of the total incident cases of BPD based on gestation period.
• Understand the magnitude of the total incident cases of BPD based on birth weight.
• Understand the magnitude of the severity of specific cases of BPD.
• The BPD epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
• The BPD Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
• Algeria
• Australia
• Canada
• China
• Egypt
• India
• Kenya
• Nigeria
• Norway
• Netherland
• South Korea
• Sweden

Study Period: 2017–2030
The study conducted by Csaba Siffel et al. (n.d.) titled “Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review” evaluated the global incidence of BPD among infants born extremely preterm. In this study, a systematic review of the literature was conducted in Embase and MEDLINE (via PubMed) using a pre-specified search strategy for BPD and prematurity. Among which observational studies published in English between 16 May 2006 and 16 October 2017 reporting on the occurrence of BPD in infants born<28 weeks GA were included. Literature searches yielded the reported global incidence range of BPD which was 10–89% (10–73% in Europe, 18–89% in North America, 18–82% in Asia, and30–62% in Oceania).
Richard AE et al. (n.d.) had conducted a study titled “Validation of the National Institutes of Health Consensus Definition of bronchopulmonary Dysplasia” for the predictive validity of the severity-based, consensus definition of BPD as per the National Institute of Child Health and Human Development (NICHD)/National Heart, Lung, and Blood Institute Workshop (June 2000). This specific workshop had proposed a severity-based definition of BPD for infants 28 days but not at 36 weeks’ postmenstrual age (PMA) or discharge, severe BPD as O2 for ?28 days plus ?30% O2 and/or positive pressure at 36 weeks’ PMA. The data from 4866 infants (birth weight <1000g, GA <32 weeks, alive at 36 weeks’ PMA) who were entered into the NICHD VLBW Infant Registry and Follow-up data of 3848 were compared among infants with the consensus definition of BPD.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Eosinophilic Esophagitis - Epidemiology Forecast to 2030

  • $ 3750
  • February 2021
  • 90 pages

‘Eosinophilic Esophagitis (EoE) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the historical and forecasted epidemiology of EoE in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Digestive System Disorder
  • Epidemiology
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on